Aspiriant Holdings S3 Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$3.87M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$3.1M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$1.97M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$1.29M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$941K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$17M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$3.14M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$2.06M |
| 4 |
Cummins
CMI
|
+$1.98M |
| 5 |
Range Resources
RRC
|
+$1.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.2% |
| 2 | Technology | 11.43% |
| 3 | Healthcare | 10.96% |
| 4 | Industrials | 8.19% |
| 5 | Communication Services | 7.22% |
Similar funds
Aspiriant Holdings S3's Q4 2014 Portfolio in Review
As of Q4 2014, Aspiriant Holdings S3 held 117 positions worth $242M, down 2.8% from $249M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aspiriant Holdings S3 withdrew a net $17.3M in Q4 2014, closing 6 positions and reducing 53 holdings. Its most notable exit was iShares MSCI Germany ETF, an estimated $3.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Aspiriant Holdings S3 opened a new position in VanEck Pharmaceutical ETF worth $3.9M.
- Aspiriant Holdings S3's largest Q4 2014 buy was VanEck Pharmaceutical ETF: 60,765 shares worth $3.9M.
- Aspiriant Holdings S3 added most to Qualcomm in Q4 2014, an estimated $488K increase.
- Aspiriant Holdings S3's biggest Q4 2014 reduction was Schwab US Large- Cap ETF, cutting an estimated $17M.
- Aspiriant Holdings S3 fully exited iShares MSCI Germany ETF in Q4 2014, selling an estimated $3.14M.
- Aspiriant Holdings S3's ten largest holdings make up 26% of its $242M portfolio in Q4 2014.
- Aspiriant Holdings S3 opened 9 new positions and closed 6 in Q4 2014.
- Aspiriant Holdings S3's portfolio value fell 2.8% quarter-over-quarter to $242M.
Based on Aspiriant Holdings S3's 13F filing for Q4 2014, filed 18 Feb 2015.